Immunogenetic modulation of endothelial inflammation by the LIPG −384A/C promoter variant influences COVID-19 severity

HariOm Singh, Aishwarya Nair, Meenakshi Bhattacharya, Gaurav Tripathi, Shamama Nishat, Abdullah F. AlAsmari, Nemat Ali

Open source

DOI
10.3389/fimmu.2026.1785738
Published
2026-06-03
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1785738,
  title = {Immunogenetic modulation of endothelial inflammation by the LIPG −384A/C promoter variant influences COVID-19 severity},
  author = {HariOm Singh and Aishwarya Nair and Meenakshi Bhattacharya and Gaurav Tripathi and Shamama Nishat and Abdullah F. AlAsmari and Nemat Ali},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1785738},
  url = {https://doi.org/10.3389/fimmu.2026.1785738}
}

RIS

TY  - JOUR
TI  - Immunogenetic modulation of endothelial inflammation by the LIPG −384A/C promoter variant influences COVID-19 severity
AU  - HariOm Singh
AU  - Aishwarya Nair
AU  - Meenakshi Bhattacharya
AU  - Gaurav Tripathi
AU  - Shamama Nishat
AU  - Abdullah F. AlAsmari
AU  - Nemat Ali
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1785738
UR  - https://doi.org/10.3389/fimmu.2026.1785738
ER  - 

APA

Singh, H., Nair, A., Bhattacharya, M., Tripathi, G., Nishat, S., AlAsmari, A. F., & Ali, N. (2026). Immunogenetic modulation of endothelial inflammation by the LIPG −384A/C promoter variant influences COVID-19 severity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1785738

Source records